单剂维生素B1对因急性疾病需要有创机械通气患者氧耗的影响:一项II期随机双盲安慰剂对照试验
本研究为在美国一家三级医院ICU开展的II期随机双盲安慰剂对照试验,纳入因急性疾病需机械通气的患者,基线测量氧耗及乳酸、中心静脉血氧饱和度、丙酮酸脱氢酶后,单剂给予200 mg静脉维生素B1或安慰剂,随后监测氧耗6小时并复查实验室指标。67例入组,排除11例氧耗数据数量或质量不足后56例纳入分析,研究药物后6小时内氧耗变化无差异,次要结局同样阴性。预设的18例维生素B1缺乏亚组中两条氧耗曲线有差异(p=0.006),但氧耗中位数或曲线下面积无差异。作者结论为单剂静脉维生素B1未改变因急性疾病需机械通气患者的氧耗。
要点
- 因急性疾病需机械通气的56例可分析患者中,单剂200 mg静脉维生素B1后6小时内氧耗变化与安慰剂无差异。
- 预设的18例维生素B1缺乏亚组中,两组氧耗曲线有差异(p=0.006),但氧耗中位数或曲线下面积无差异。
- 乳酸、中心静脉血氧饱和度、丙酮酸脱氢酶数量与活性等次要结局同样为阴性。
- 67例入组,11例因氧耗数据数量或质量不足被排除,最终56例纳入分析。
- 单剂静脉维生素B1未改变因急性疾病需机械通气患者的氧耗(作者结论)。
适用人群与场景
- 美国一家三级医院ICU收治、因急性疾病需要有创机械通气的患者被筛查入组。
- 67例入组,排除11例因氧耗数据数量或质量不足者后,56例纳入分析。
处置流程与药物剂量
- 入组后先测基线氧耗及基线实验室检查(包括乳酸、中心静脉血氧饱和度和丙酮酸脱氢酶),随后单剂给予200 mg静脉维生素B1或安慰剂。
- 给药后继续监测氧耗6小时,并在方案结束时复查实验室指标。
研究设计与关键结果
- II期随机双盲安慰剂对照试验,在美国一家三级医院ICU开展,67例入组、56例纳入分析。
- 研究药物后6小时内氧耗变化在维生素B1组与安慰剂组间无差异。
- 次要结局(乳酸、中心静脉血氧饱和度、丙酮酸脱氢酶数量与活性)结果同样为阴性。
- 预设的18例维生素B1缺乏亚组中,两组氧耗曲线有差异(p=0.006),但氧耗中位数或曲线下面积无差异。
证据类型、等级与局限
- 证据类型:II期随机双盲安慰剂对照试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论:单剂静脉维生素B1未改变因急性疾病需机械通气患者的氧耗;原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: Lower oxygen consumption is associated with worse survival in septic shock and in other forms of critical illness. No treatment that increases oxygen extraction, a key determinant of oxygen consumption, has been found. Thiamine is required for aerobic metabolism, and deficiency is common in the critically ill.
OBJECTIVES: We evaluated the effect of thiamine on oxygen consumption in patients requiring mechanical ventilation for an acute illness.
DESIGN: Phase II, randomized, double-blind, and placebo-controlled trial.
SETTING AND PARTICIPANTS: ICUs in a tertiary care hospital in the United States. Patients admitted to the ICU and requiring mechanical ventilation were screened for enrollment.
INTERVENTIONS: After enrollment, baseline measurement of oxygen consumption and baseline laboratories including lactate, central venous oxygen saturation, and pyruvate dehydrogenase, a single dose of 200 mg IV thiamine or placebo was administered. Oxygen consumption was then monitored for 6 additional hours and repeat laboratories were drawn at the end of the protocol.
MAIN OUTCOMES AND MEASURES: The primary outcome was the change in oxygen consumption. Analysis was done using linear regression with a first-order autoregressive variance-covariance structure to account for repeated measures within subjects. Secondary outcomes included change in lactate, central venous oxygen saturation, and pyruvate dehydrogenase quantity and activity.
RESULTS: Sixty-seven patients were enrolled. After excluding 11 patients due to inadequate quantity or quality of oxygen consumption data, 56 patients were included. There was no difference in change in oxygen consumption in the 6 hours after study drug. Results for secondary outcomes were similarly negative. In the prespecified subgroup of 18 thiamine deficient patients, there was a difference in the two oxygen consumption curves (p = 0.006), although no difference in median oxygen consumption or area under the curve.
CONCLUSIONS AND RELEVANCE: A single dose of IV thiamine did not alter oxygen consumption in patients requiring mechanical ventilation for acute illness.
参考来源
- Berg KM, Grossestreuer AV, Andersen LW, et al. The Effect of a Single Dose of Thiamine on Oxygen Consumption in Patients Requiring Mechanical Ventilation for Acute Illness: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial. Crit Care Explor. 2021. PMID: 34806022. doi:10.1097/CCE.0000000000000579
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。